Suchergebnisse - "Elise Siegert"

PubPharm (10)

1

The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis—Interstitial Lung Disease in the European Scleroderma Trial and Research Database

in: Diagnostics | 2024

von Gemma Lepri | Cosimo Bruni | Lorenzo Tofani | +24

2

Endothelin B Receptor Immunodynamics in Pulmonary Arterial Hypertension

in: Frontiers in Immunology | 2022

von Christoph Tabeling | Christoph Tabeling | Christoph Tabeling | +28

3

Autoimmunity to Sphingosine-1-Phosphate-Receptors in Systemic Sclerosis and Pulmonary Arterial Hypertension

in: Frontiers in Immunology | 2022

von Hans Gluschke | Elise Siegert | Elise Siegert | +8

4

SIGLEC-1 in Systemic Sclerosis: A Useful Biomarker for Differential Diagnosis

in: Pharmaceuticals | 2022

von Jakob Höppner | Vincent Casteleyn | Robert Biesen | +4

5

Performance of ENMC and EULAR/ACR classification systems applied to a single tertiary center cohort of dermatomyositis patients

in: Neurological Research and Practice | 2021

von Jan Zoske | Udo Schneider | Elise Siegert | +4

6

Health Assessment Questionnaire-Disability Index (HAQ-DI) use in modelling disease progression in diffuse cutaneous systemic sclerosis: an analysis from the EUSTAR database

in: Arthritis Research & Therapy | 2020

von Yannick Allanore | Sylvie Bozzi | Augustin Terlinden | +14

7

Selenium and Copper as Biomarkers for Pulmonary Arterial Hypertension in Systemic Sclerosis

in: Nutrients | 2020

von Qian Sun | Julian Hackler | Julia Hilger | +5

8

Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group

in: Arthritis Research & Therapy | 2018

von Sabine Adler | Dörte Huscher | Elise Siegert | +14

9

Antibodies against chemokine receptors CXCR3 and CXCR4 predict progressive deterioration of lung function in patients with systemic sclerosis

in: Arthritis Research & Therapy | 2018

von Florian Weigold | Jeannine Günther | Moritz Pfeiffenberger | +14

10

06.08 Low-dose il-2 therapy in refractory sle: results from a single centre phase i/iia clinical trial

enthalten in: Annals of the rheumatic diseases | 2017

von Jens Y Humrich | Caroline von Spee-Mayer | Elise Siegert | +9

1
[1]